Inactive Instrument

Zeltia SA Stock

Stocks

ES0184940817

Biotechnology & Medical Research

End-of-day quote BME
- ^EUR	-

11/11/15	Alibaba's Singles' Day sales surge 60 percent to $14.3 billion	RE
04/11/15	Alibaba : China consumers to spend more in November 11 'Singles Day' shopping spree - Nielsen	RE

Latest news : Zeltia SA

11/11/15	Alibaba's Singles' Day sales surge 60 percent to $14.3 billion	RE
04/11/15	Alibaba : China consumers to spend more in November 11 'Singles Day' shopping spree - Nielsen	RE
17/12/14	Hyundai Heavy : Thomson Reuters/INSEAD Asia Business Sentiment Survey fourth quarter 2014 - PDF	RE
17/12/14	Hyundai Heavy : Thomson Reuters/INSEAD fourth quarter Asian Business Sentiment Survey - by economy	RE
17/12/14	Hyundai Heavy : Thomson Reuters/INSEAD fourth quarter Asian Business Sentiment Survey - by sector	RE
03/11/14	Inditex : Daughter of Zara founder declares 5 percent Inditex stake	RE
05/02/14	Bell Aliant Inc : Canada tightens rules on cellphone towers	RE
17/12/13	Vodafone Group plc : Insight - The Luxembourg tax break that helps firms profit from loss	RE
19/10/13	Google Inc : Google shares break $1,000 barrier as mobile pays off	RE
18/10/13	Berkshire Hathaway Inc. : Google shares break $1,000 barrier as mobile pays off	RE
18/10/13	Canadian Solar Inc. : China's pioneers to drive recovery in solar equipment demand	RE
17/10/13	Verizon Communications Inc. : Telecom tycoon says Ottawa's policy imperils Wind, foreign investment	RE

Press Releases: Zeltia SA

26/10/15	Zeltia : PharmaMar to Present New Studies for YONDELIS® and PM1183 in Ovarian Cancer during ESGO 2015	PU
23/10/15	Zeltia : U.S. FDA Approves YONDELIS® (trabectedin) for Soft Tissue Sarcoma (Liposarcoma or Leiomyosarcoma)	PU
21/10/15	Zeltia : Grupo Zeltia reports 126.8 million euro in net sales (+8.5%) in the first nine months of 2015	PU
21/09/15	Zeltia : Enrollment of first patient in a Phase II trabectedin study in brain tumor type called meningioma	PU
17/09/15	Zeltia : PharmaMar initiates a phase II “Basket” trial for PM1183 in selected advanced solid tumors	PU

More press releases

News in other languages: Zeltia SA

15/12/15	DJ Industrial : Wall Street termine dans le vert une séance volatile
17/11/15	China CITIC Bank : Les valeurs à suivre sur les marchés américains
29/07/15	DJ Industrial : Wall Street finit en hausse, les craintes sur la Chine refluent
28/07/15	DJ Industrial : Wall Street plombée par la chute des Bourses chinoises
26/05/15	Les valeurs à suivre sur les marchés américains

Other Biotechnology & Medical Research

	Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
	LONZA GROUP AG	+2.37%	+0.66%	+4.21%	+22.74%	48.63B
	REVOLUTION MEDICINES, INC.	-0.62%	+4.43%	+488.92%	+624.71%	46.3B
	BEONE MEDICINES AG	+2.09%	+4.90%	+18.02%	+95.21%	41.97B
	IQVIA HOLDINGS INC.	+3.85%	+2.23%	+29.47%	+16.50%	39.51B
	CELLTRION, INC.	-0.72%	-7.79%	+17.87%	+47.98%	31.75B
	MEDPACE HOLDINGS, INC.	+3.04%	+0.46%	+31.40%	+143.62%	16.48B
	ASCENDIS PHARMA A/S	+4.33%	+1.98%	-	-	16.34B
	EUROFINS SCIENTIFIC SE	+1.44%	+1.09%	+4.93%	+31.00%	14B
	CHARLES RIVER LABORATORIES INTERNATIONAL, INC.	+3.87%	+2.84%	+84.74%	+45.80%	13.33B
	Average	+2.00%	-0.60%	+84.94%	+128.44%	29.81B
	Weighted average by Cap.	+1.77%	-0.05%	+107.33%	+157.21%

See all sector performances

Company Profile

Employees

-

Sector

Biotechnology & Medical Research

More about the company

The best tools reserved for subscribers to boost the performance of your investments!